Echo Therapeutics Inc fka ECTE

[SD1527]

I gotcha. Yes, the CEO is very impressive in addition to the company's offering and near-term potential.

Looking at some close comps - as mentioned in the CEO interview - like Dexcom leads me to believe that Echo could mature significantly if it stays on track with plans to bring at least 1 FDA approved medical device to the public in 2010.

From where I see, ECTE is one FDA-Approval and one or two licensing agreements away from being a $5 stock or higher. I really hate to speculate on PPS increases, but that seems fair to me considering that the Symphony CBGM system would be the first needle-free system (i.e. a revolutionary product with a massive and growing addressable market) available to check Diabetic blood sugar/glucose, etc.

Any thoughts?